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Abstract
Mycobacterium tuberculosis (Mtb), the causative agent for the disease
Tuberculosis (TB) in humans, is present as a latent infection in approximately one third
of the world’s population. Mtb has become more resilient over the years. The vaccine,
Mycobacterium bovis bacillus Calmette-Guerin (BCG), loses effectiveness 10 years after
initial vaccination. Recent research has found 6-kD early secretory antigenic target
(ESAT-6) and 10-kD culture filtrate protein (CFP-10) are secreted as a heterodimer by
Mtb and play important roles in virulence. Additionally, ESAT-6 has been determined to
contain membrane lytic activity while CFP-10 has been suggested to be a molecular
chaperone. Studies suggest ESAT-6 dissociates from CFP-10 at low pH to interact with
the phagosomal membrane, which facilitates the translocation of Mtb into the cytosol of
a macrophage. Furthermore, membrane lytic ability of ESAT-6 only occurs after it
dissociates from CFP-10. However, the mechanism of heterodimer dissociation remains
elusive. Previous studies have identified and isolated an N-α-terminally acetylated ESAT6 protein. Binding affinity between CFP-10 and ESAT-6 is greatly reduced after
acetylation, suggesting that N-α-terminal acetylation could be the cause for the
dissociation of the ESAT-6/CFP-10 heterodimer. In this study, we aim to determine
whether N-α-terminal acetylation of Threonine-2 (T2) on ESAT-6 is required for
dissociation of the heterodimer. To test this, we replaced T2 with three different amino
acids alanine (T2/A), glutamine (T2/Q), and arginine (T2/R). We hypothesized T2/A and
T2/Q would function as acetylation-mimicking residues with similar activity to wild-type
ESAT-6, while T2/R serves as acetylation negative control with less activity. Preliminary
data, a liposome leakage assay with the dye/quencher pair, 8-aminonaphthalene-1,3,6
trisulfonic acid (ANTS) and p-xylene-bis-pyridinium bromide (DPX), revealed that all of
v

these mutations did not affect pore formation of ESAT-6 alone, but diminished pore
formation of the ESAT-6 complexed with CFP-10. This data suggested T2/A, T2/Q and
T2/R mutations inhibited heterodimer dissociation, prompting generation of a new T2/S
mutant. Cytotoxicity analysis of macrophages infected by Mycobacterium marinum
revealed decreased activity in the mutants while complemented strains with WT ESAT-6
or T2/S ESAT-6 recovered activity. As expected, the mutations inhibited the cytosolic
translocation as measured by CCF4 fluorescence resonance energy transfer (FRET). The
change in virulence was presumed to be due to the lack of acetylation in the T2/Q, T2/R,
and T2/A mutants. Isolation of acetylated ESAT-6 was achieved via ASB-14 or 6M
guanidine and was confirmed via 4-chloro-7-nitrobenzofurazan (NBD-Cl) and mass
spectrometry. Native gel shift assay revealed un-acetylated ESAT-6 to form a complex
with CFP-10 more efficiently than acetylated ESAT-6. Furthermore, preliminary studies
using surface plasmon resonance revealed differential binding affinity between either
specie of ESAT6. This study has revealed the physiological importance of N-α-acetylation
of ESAT-6 in Mtb infection.
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Chapter 1: Introduction

Mycobacterium tuberculosis (Mtb) is the causative agent for tuberculosis (TB), a
disease present as a latent state in approximately one third of the world population
(Zumla, 2014; WHO, 2016). The disease is responsible for over 1 million deaths each
year (CDC, 2015). Much progress has been made in understanding the mechanisms of
Mtb infection. Previous reports show that Mtb is internalized by a macrophage into a
phagosome; however, the pathogen is capable of translocation from phagolysosome
into the cytosol of an infected macrophage (Van Der Wel, N. 2007). It has been well
established that the complex named ESX-1 is important in Mtb pathogenesis. The ESX1 complex mediates the secretion of 6-kD early secretory antigenic target (ESAT-6) and
10-kD culture filtrate protein (CFP-10), two proteins secreted as a heterodimer (Fortune,
S., 2005), which allow Mtb to rupture the phagosome and translocate into the cytosol of
the host cell (Houben, D., 2012; Smith, J., 2008; Renshaw, P.S., 2002).
1.1 Facts and Statistics
Mtb is one of the leading causes of death worldwide; approximately 9.6 million people
were estimated to have fallen ill with TB in 2014 (Dolin 1994, CDC, 2016). Quick
progression of the disease was observed in 2015, where the numbers rose to a total 10.4
million people becoming sick with the disease and 1.8 million people dying from TBrelated deaths (CDC, 2016). TB is most prevalent in underdeveloped countries such as
those found in Africa. A more particular threat in that region exists with co-infection with
HIV and TB. An estimated 1.2 million people were co-infected with HIV and Mtb.
Approximately a third of the deaths caused by HIV are a result of TB (Komrower, 2015;
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Venturini, 2015). Furthermore, drug resistant TB has shown an increase in incidence with
approximately 480,000 cases of drug resistant TB in 2015. (CDC, 2016) TB is one of the
leading causes of death in the world, having surpassed even HIV, prompting the urgency
to develop better therapeutic options. Though the disease has caused shiver inducing
death numbers, it is important to note that millions of cases have been treated
successfully. Continued growth and dedication from the scientific field is essential to the
abolishment of the disease.
1.2 Treatment of a Typical Mtb Infection
Mtb is a very resilient bacterium that requires a long antibiotic treatment regimen.
The typical treatment of TB disease includes a cocktail of four antibiotics that are taken
for six to nine months and sometimes longer. The core antibiotic treatment includes
isoniazid, rifampin, ethambutol, and pyrazinamide. The typical treatment regimen
includes daily intake of the four antibiotics for 8 weeks. After 8 weeks, the dose is lowered
to a daily intake of isoniazid and rifampin for 18 weeks, or intake of isoniazid and rifampin
twice per week for 18 weeks (CDC, 2016). Resolution of the disease is often observed
after the 18 week treatment, though in certain occasions the treatment may be longer.
Mycobacteriaare highly prone to gaining antibiotic resistance, and thus treatment
regimens require very attentive and consistent dosage.
1.3 Rise of Antibiotic Resistant TB Defines New Borders
A particularly alarming occurrence, which is becoming more frequent, is the
development of drug resistant TB. Patients at risk of developing drug resistant TB include
those who do not take their antibiotics regularly, do not take all of their TB drugs, use
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drugs of poor quality, or develop TB disease again amongst other reasons. As defined
by the WHO there are different types of drug resistant TB. Multidrug-Resistant TB (MDRTB) is resistant to isoniazid and rifampin, and Extensively Drug-Resistant TB (XDR-TB)
is resistant to isoniazid, rifampin, any fluoroquinolone, and at least one injectable second
line drug. (CDC, 2006) Not yet defined by the WHO, cases of Totally Drug-Resistant TB
(TDR-TB) have been reported (Velayati, A., 2009; Udwadia, Z. F., 2012, Klopper 2013).
These strains appear to have developed resistance to every possible treatment option.
The development of any drug resistant strain is a serious matter that progresses quickly.
MDR-TB is now seen in approximately 5% of cases, while at least 40,000 cases of XDRTB occur every year. Progression of antibiotic resistance could revert bring back
humanity into a pre-antibiotic era. For this same reason, research for the rapid
development of new therapeutics against TB is crucial.
1.4 Regions of Difference Give Insight on Virulent Genes
The advancement of genomic studies serves an instrumental role in identifying
genes essential for pathogenic bacteria. As has been well established, co-evolution
between host and pathogen favors the adaptation of pathogen to host immunities. These
specific alterations in the genome of a pathogen become imperative to the pathogen’s
survival. The genes responsible for the virulence of a pathogen in a host have been
appropriately termed virulent genes. The successful identification and inhibition of the
virulent genes comprise a potential therapeutic target. Comparative analyses between
virulent species of mycobacteria have illustrated 14 regions of difference (RD1-14), which
have been implicated in recent studies (Gordon, 1999; Behr 1999). As expected,
genome-wide analysis revealed the H37Rv Mtb strain to contain RD1-14, while the
3

attenuated M. bovis var. BCG strain lacks them. Furthermore, another 6 regions H37Rv
deletion 1-5 (RvD1-5) as well as Mtb. specific deletion 1 (TBD1) have been identified
(Brosch 1999). All of these regions code for a variety of virulent factors, conferring Mtb
its fundamental systems to thrive as a pathogen. As expected, targeting these genes is
a major point of interest for the development of novel therapeutics.
1.5 Key Mechanisms for Mtb Pathogenesis
Mtb possesses many qualities that make it a successful pathogen. These qualities
include the intricate cell wall accessorized by complex lipids. Ancillary to a strong cell
wall Mtb has the ability to arrest phagosomal maturation in a macrophage (Chua 2004;
Hoffman 2017), resistance to reactive nitrogen species (RNS) and reactive oxygen
species (ROS) (Piddington, 2001; Kendall, 2004; Voskuil, 2003), adaption for catabolism
(McKinney, 2000; Segal, 1956; Pandey, 2008), and the secretion of important virulence
factors (Conrad, 2017; Abdallah 2007). All of these key properties of Mtb are what makes
it such a strong pathogen.
The cell envelope of mycobacteria is composed of an intricate cell wall with
complex lipids; it consists of an inner membrane, peptidoglycan and arabonigalactan
layers, a mycolic acid layer and an outer capsular layer. The cell wall of Mtb has been
shown to contain over 500 proteins, out of which 150 outer membrane proteins have
been identified as important virulence factors (Wolf, 2010), the role of these proteins
varies from transfer and synthesis of sugars and other molecules (Murphy, 2005;
Senaratne, 1998; Braibant, 2000), or serving as ligands (Casali, 2007). A strong cell
envelope accessorized by complex lipids is essential for Mtb’s survival.
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Complex lipids are characteristic of mycobacteria many of which are adaptive
effectors of virulence. Fortifying the tough cell wall of mycobacteria are the mycolic acids:
trehalose monomycolates (TMM) and trehalose dimycolates (TDM) which are covalently
attached to arabinogalactan and sterified to glycerol and trehalose (Brennan, 1995).
Furthermore, additional lipids and glycolipids include di-acylated trehaloses(DAT), triacylated trehaloses(TAT), poly-acyltrehaloses (PAT), sulfolipids (SL), phthiocerol
dimycocerosates (PDIM), and found in hypervirulent strains of Mtb, phenolic glycolipids
(PGL) (Mamadou, 1997; Jia 2012). All of these complex lipids have key roles in Mtb
virulence, and have been suggested to work in essential pathways of infection.
Although Mtb possesses a plethora of lipids, of its own, another key element is its
ability to use other lipids or compounds as a carbon source. Mtb is capable of
metabolizing fatty acids, lipids and cholesterol. Metabolizing fatty acids and lipids has
been implied to play a role in the ability for Mtb extra-pulmonary infection (Rindi 2002).
Catabolism of cholesterol has been one of the most surprising properties innate to Mtb
and has served as a therapeutic target (Miner, 2009; Hughes, 2011). A sophisticated
network of protein interactions makes this pathway possible for Mtb, and cholesterol
plays a crucial role for the synthesis of PDIM (Pandey, 2008; Griffin 2011).
Some of the properties of Mtb, particularly those originating from the fortified cell
envelope, confer the pathogen resistance to macrophage offensive action. Mtb has
shown resistance to RNS or ROS (Voskuil, 2011; Cirrillo 2009). Macrophages generally
produce ROS and RNS which contain powerful bactericidal properties. Mtb has
developed unique pathways that allow resistance to these anti-bacterial compounds.
Some virulence factors expressed by Mtb allow for the breakdown of ROS/RNS, while
5

others provide the bacteria with tolerance (Piddington, 2001; Voskuil 2003). Ability of the
pathogen to resist macrophage action is extremely relevant to TB research.
Similarly, another key characteristic of Mtb is its ability to arrest phagosomal
maturation. (Vergne, 2004) In a typical infection, the first line defensive cell of the human
body, the macrophage, phagocytizes pathogens into a phagosomal compartment. The
phagosome will then fuse with lysosomes to turn into a phagolysosome. This fusion is
normally a death sentence for a pathogen; however Mtb has evolved mechanisms that
inhibit this action. Some key virulence factors of Mtb have been shown to inhibit the
recruitment of effectors to phagosomes, or inhibit acidification of the phagosome (Sun,
2010; Wong, 2011; Iantomasi, 2012). The pathogen is then capable of translocating from
the phagosome into the cytosol through a number of pathways not yet well understood
where Mtb is capable of continuing infection.
More relevant to the line of research in this project, Mtb also makes use of a wide
array of secreted proteins. Mtb has been shown to contain many different secretion
systems, but more importantly the type II and type VII secretion systems have been
implied to have a key role in virulence of the pathogen (Abdallah, 2007). Moreover, the
mycobacterial specific type VII secretion system has been particularly well studied and
includes five homologous secretion systems termed ESX 1-5 (Houben, 2014). Out of
these 5, ESX-1 and ESX-5 have been correlated with virulence of Mtb. The ESX-1
secretion system is the most heavily researched of these and consists of two effector
proteins 6-kDa Early Secretory Antigenic Target (ESAT-6) and 10-kDa culture filtrate
protein (CFP-10), whose interaction is the key topic of this thesis (Simeone, 2009).
1.6 Secretion Systems of Mtb Contain Essential Virulence Factors
6

The type VII secretion system contains ESX-1, which is a key secretion system for
Mtb. The two effector proteins ESAT-6 and CFP-10, collectively known as esx-1 have
been demonstrated to be vital virulence factors (Sørensen, 2009). Also located within the
ESX-1 are auxiliary proteins including EccA, EccB, EccC, EccD, EspA, EspB, EspC, and
EspD proteins whose role has not been studied quite as well as the effector proteins
(Stoop, 2012; Wirth, 2012; Rosenberg, 2015). Interestingly interdependence for each
other was found between secreted proteins of ESX-1, if ESAT-6 is deleted EspB could
also be affected. More meaningful to the collective virulence of these genes, their
localization in RD1 implies their relevance. When RD1 was removed from virulent strains
of Mtb, attenuation of these strains occurred (Pym, 2002). Moreover, complementation of
RD1 to non-pathogenic BCG strains showed restored virulence (Kristi 2004).
Furthermore, complementation of BCG with ESAT-6 conferred better immunities of the
vaccine strain (Pym, 2003; Groschel, 2017). It is specifically for these reasons that many
studies have focused their efforts into this gene and have established a portion of its role.
Many different roles have been tied to esx-1 which include phagosomal maturation arrest
(Tan, 2006), cytosolic translocation of Mtb (van der Wel, 2007; Houben, 2012), and has
been implied to take a role in a DNA sensing pathway (Watson, 2012) or synergize with
other virulence factors such as PDIM (Augenstreich, 2017). The exact role has not been
fully elucidated, but it is very clear that esx-1 has a key role in cytosolic translocation of
Mtb. Without a doubt, the esx-1 is a very important virulence factor of Mtb.
1.7 Esx-1 Confers Essential Virulent Properties to Mtb
ESAT-6, accompanied by CFP-10, is responsible for membrane cell-lysis
(Houben, D., 2012; de Jonge, M. I., 2007). Studies have shown that BCG lacks both
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ESAT-6 and CFP-10 and is not able to rupture the phagosome membranes in
macrophages, suggesting that ESAT-6 is a determining factor for Mtb pathogenesis.
(Brosch, R. 2007; Mahairas, G., 1996; Berh, M. A., 1999). Additionally, it was determined
that CFP-10 does not contain membrane-lytic activity, rather it is an intrinsic property
of ESAT-6 alone; CFP-10 behaves as a molecular chaperone of ESAT-6 (de Jonge, M.
I., 2007). Current studies have proposed that under acidic condition ESAT-6 is
dissociated from CFP-10, an essential step for ESAT-6 to interact with the membrane.
(de Leon, J., 2012; de Jonge, M. I., 2007) However, the mechanism of ESAT-6/CFP10 dissociation remains unclear.
1.8 General Structure and Interaction of the ESAT-6 and CFP-10 Complex
The structure for CFP-10 and ESAT-6 is
formed by two helical hairpin structures composed
of a helix, bridge, and another helix with C- and Nterminal flexible arms. The helices have extensive
hydrophobic surfaces. Interaction of the two
proteins is based on van der Waals contacts, while
two salt bridges stabilize the N-terminal helix-1 of
CFP-10 to the C-terminal helix-2 of ESAT-6, and
the C-terminal helix-2 of CFP-10 to N-terminal
Figure 1: Solution structure of
ESAT-6 and CFP-10 complex
(Protein Data Bank ID 1WA8)

ESAT-6 helix-1 (Renshaw, P. S. 2005). . The length
of helices 1 and 2 from ESAT-6 were measured to
be ~50 Å spanning the depth of a typical membrane,
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and C- and N- terminal flexible arms have been shown essential for membrane
disruption of ESAT-6 (Ma, Y., 2015).
1.9 Specific Mechanism of Action of ESAT-6 and CFP-10 Remains Elusive
Though the esx-1 complex has been heavily researched in the past decades,
there is still much debate within the scientific community of its exact mechanism of action.
Previous research has suggested CFP-10 to function as a molecular chaperone. ESAT6 and CFP-10 form a tight 1:1 heterodimer. Dissociation of this complex must occur
before ESAT-6 is capable of membrane lysis. The mechanism underlying dissociation
remains elusive. In spite of all controversy, it is clear that ESAT-6 is essential for cytosolic
translocation of Mtb. It appears that acidification of the protein prompts or plays an
important role in the dissociation of the heterodimer complex (de Jonge M. I., 2007), as
it has shown to prompt increased folding and organization via more α-helical structure of
ESAT-6 (Ma, 2015). For this reason and others, lowering the pH has been implied to
serve as a trigger for the dissociation of ESAT-6 from its molecular, citing the conditions
found within a macrophage. (Kupz, 2016; Zhang, 2016) Others have found evidence to
suggest differently. (Conrad, 2017). However, different preparations of ESAT-6 might
determine the discrepancy between the results of different research groups. Some
groups prepared their ESAT-6 proteins via expression in E. coli versus other groups
preparing ESAT-6 in M. smegmatis. Preparations in E. coli resulted in a protein that
lacked N-α-terminal acetylation while those in M. smegmatis resulted in a protein that
contained this type of acetylation and may be important for the dissociation of the
heterodimer complex.
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1.10 Acetylation at the N-terminus Could Be the Driving Factor For the pHDependent Dissociation of the Heterodimer Complex
An earlier report showed ESAT-6 is acetylated at its N-terminus in mycobacteria,
and displayed differential binding to its un-acetylated version (Okkels, L. M., 2004).
ESAT-6 has been implicated as a unique virulence factor capable of N-α-terminal
acetylation (Lange S., 2014). The importance of acetylation was observed in another
study (Medie, F. M., 2014), where an inverse correlation between the virulence of M.
marinum and the acetylation of ESAT-6 was proposed. It was previously observed by
(de Jonge, M. I., 2007) that ESAT-6 is incapable of interacting with the membrane when
it forms a complex with CFP-10. Given these premises, we hypothesize that N-αacetylation of ESAT-6 at the second residue, threonine-2 (T2), is essential for the
dissociation of the heterodimer complex.
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Chapter 2: Specific Aims
2.1 Determine the Effects of Mutations at T2 of ESAT-6.
For this portion of the project, various mutations were generated in ESAT-6. These
mutations will be used to compare the lysing ability of ESAT-6 in vitro. Further studies
were performed in vivo using M. marinum as a model. Mutated ESAT-6 was compared in
cytotoxicity of RAW 264.7 macrophages. Furthermore, ability of cytosolic translocation
was compared among all strains. Appropriate control for secretion of ESAT-6 was
performed as well.
2.1.1 Generate Mutations at T2 in ESAT-6 in Different Vectors
As previous literature has indicated that the ESAT-6 protein is acetylated at its Nterminal T2 residue (Okkels, 2004). To be able to effectively determine the role of
acetylation at T2, mutations were introduced to replace T2 with an alanine (T2A), arginine
(T2R), glutamine (T2Q), or serine (T2S). These mutations were performed in pET22B
plasmid for expression and purification of ESAT-6 in BL21 E. coli cells, pMyNT for
expression and purification of ESAT-6 complexed with CFP-10 in M1552 M. smegmatis
cells, and pMH406 for complementation of ESAT-6 into M. marinum. In this study, T2S
demonstrated similar function as wild type, while T2A and T2Q and T2R did not
(Scroggins, 2007).
2.1.2 Determine the Effect of Mutations in ESAT-6 Towards Cell Lysing Ability
In Dr. Jianjun Sun’s laboratory, a liposome leakage model has been developed for
reliable detection of protein pore formation (De Leon 2012; Jacquez, 2014; Jacquez,
2015), which was used to compare the membrane lytic activity between wild-type and
11

mutated ESAT-6. Effects of mutations were assessed on both complexed and lone ESAT6.
2.1.3 Determine the Effect of Mutations in Cytotoxicity of Macrophages.
To complement this data, in vivo infections using M. marinum as a model were
performed in Raw264.7 macrophages. An M. marinum strain with a knocked out ESAT-6
gene (KO) was previously generated and is particularly useful in this study. The knock
out bacteria was electroporated with ESAT-6 containing T2S, T2A, T2Q, or T2R, and wildtype ESAT-6 serving as a positive electroporation control (MmΔE6/C10(WT)). The
macrophages were infected with the 5 complemented strains as well as the wild-type
(WT) M. marinum and KO strain. The macrophages were stained with ethidium
homodimer and calcein-AM, as part LIVE/DEAD viability/Cytotoxicity Kit (L3224,
Molecular Probes, Eugene Oregon, USA) to compare the number of macrophages killed
by WT versus the strains containing the mutated ESAT-6. The infected cells were
visualized under a fluorescence microscope, with green-fluorescent cells indicating live
cells and red-fluorescent cells indicating dead cells.
2.1.4 Determine the Effects of Mutations in M. marinum Cytosolic Translocation
Translocation of M. marinum from a phagosomal compartment into cytosolic
space, was visualized with fluorescence resonance energy transfer (FRET) as previously
described (Acosta, Y., 2014). The host cell was loaded with a chemical probe trapped
within host cytoplasm, which reacts with beta βlactamase expressed in the surface of M.
marinum. In this assay, a shift from green to blue fluorescence represents the extent at
which bacteria is capable of escaping from the phagosome.
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2.1.5 Control for ESAT-6 Secretion.
As a control to the in vivo studies, western-blotting will be used to show that the
secretion of ESAT-6 from the mutated M. marinum strains. Mutations can be
unpredictable, therefore a control to see expression of ESAT-6 is necessary. Culture
filtrate was analyzed for secretion of ESAT-6 and cell lysate was analyzed for total
expression.
2.2 Determine the State of N-α-acetylation and Determine its Role in the
Dissociation of the ESAT-6/CFP-10 Heterodimer Complex.
To more appropriate correlate the effects of the mutation on separation between
ESAT-6 and CFP-10, mutants was used to determine the whether or not the mutated
proteins are acetylated. First, a method to isolate between acetylated and unacetylated
types of ESAT-6 was devised and confirmed. The dissociation amongst unacetylated and
acetylated types of protein was then compared.
2.2.1 Isolation of Acetylated ESAT-6.
To effectively determine if acetylation is the cause for dissociation of the ESAT6/CFP-10 complex, the state of acetylation must be compared between mutant ESAT-6
and WT ESAT-6. To isolate the acetylated ESAT-6, the protein was co-purifed as a
heterodimer with ESAT-6 and then dissociated via detergent or high concentrations of
guanidine (Renshaw, P. S., 2002; Refai, A., 2015).
2.2.2 Determination of Acetylation States of ESAT-6.
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The state of acetylation was determined using 4-chloro-7-nitrobenzofurazan (NBDCl). As shown in a previous literature (Bernal-Perez, 2012), NBD-Cl binds to the nonacetylated N-α-terminal amine group of protein, and upon binding it emits fluorescence,
while it does not bind to the N-α-terminal N-terminal amine group due to the presence of
N--acetylation, which makes it a reliable method to measure acetylation state. It is
expected that mutated proteins incapable of acetylation will have a higher fluorescence,
while proteins containing N-α-acetylation are expected to have weaker fluorescence.
To conclusively test the state of acetylation, WT ESAT-6 purified from E. coli, WT
ESAT-6 purified from M. smegmatis, T2A, and T2S proteins were tested using mass
spectrometry. As evidenced from previous studies, acetylation results in a mass increase
of 42Da. Furthermore, trypsin and pepsin digestions of each protein were performed and
analyzed for acetylation.
2.2.3 Determine the Effects of Acetylation on ESAT-6/CFP-10 Dissociation.
Given that the heterodimer complex purified from E. coli does not contain
membrane lytic ability, we hypothesize that the ESAT-6 purified from E. coli does not have
N-α-acetylation, thus it is not dissociated from CFP-10 at low pH. Here, the heterodimer
purified from M. smegmatis will be dissociated by guanidine and tested for membrane
lytic ability. It is expected that the newly separated proteins, including the mutated
proteins, will maintain their membrane lysing activity. The proteins have been found to
bind after incubation, (de Leon, 2012). Here the difference in binding efficiency of ESAT6 purified from M. smegmatis will be compared to ESAT-6 purified from E. coli by using a
native gel as previously described. Lastly, to determine the effect of acetylation on the
dissociation of the heterodimer complex, surface plasmon resonance will be used to test
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the binding affinity between ESAT-6 (WT and mutant) and CFP-10 using the methods as
previously described (Rotherham, L. S., 2012). Briefly, CFP-10 will be fixed to a CM5
sensor-chip as the ligand, while ESAT-6 will be passed as analyte. We expect the nonacetylated ESAT-6 mutants to have higher binding affinity than acetylated ESAT-6.
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Chapter 3 Experimental Approach

Figure 2: General Schematic of Methods: Project consisted of 2 major parts an in
vitro and an in vivo portion. For in vitro experiments, two plasmids containing
mutations T2A, T2Q, T2R and T2S were generated. Each plasmid was expressed and
purified using a Ni+ affinity chromatography followed by size exclusion. Resultant
proteins were tested via ANTS/DPX leakage. Heterodimer proteins were separated via
a minimum 3M guanidine and used to test acetylation state via NBD-Cl or mass
spectrometry, or to test binding affinity via native gel or surface plasmon resonance. In
vivo experiments consisted of generation of the four mutations in ESAT-6 and
expressing this gene into M. marinum. Resultant strains was used to infect Raw 264.7
cells to test for cytotoxicity and cytosolic translocation. Immunoblotting was used to
check for secretion of ESAT-6.
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3.1 Preparation of Plasmids
The mutated ESAT-6 was prepared in three different plasmids, pET22b for
expression in E. coli, pMyNT for expression in M. smegmatis and pMH406 for expression
in M. marinum.
For pET22b plasmid, the appropriate primers were used to amplify the DNA via
PCR (Table 3.1). Following PCR, samples were run on a 1 % agarose gel, and the
appropriate band was excised and extracted using a QIAGEN gel extraction procedure.
A double digestion was performed using NDE I and XHO I restriction enzymes, the
products were loaded onto a 1% agarose gel and once again extracted using a QIAGEN
gel extraction protocol. The digested inserts and vector were ligated using T4 DNA ligase.
Following ligation, the plasmids were transformed into DH5α competent cells, and
extracted via a Promega mini-prep procedure.
Mutated ESAT-6 was generated in pMH406 through site directed mutagenesis with
a QuikChange II procedure from Agilent. Briefly, primers were designed to include the
desired mutation at T2 of ESAT-6 (Table 3.1) and were used to amplify the DNA via PCR.
Following PCR, the product were digested using Dpn-1 restriction enzyme to remove
methylated DNA. Following digestion the products were transformed into XL-1 blue supercompetent cells and extracted via a Promega mini-prep procedure.
Mutations in the pMyNT plasmid were generated via an overlap PCR procedure.
Briefly, a F-primer was designed from N-terminal CFP-10 through the desired T2 mutation
ESAT-6 as R-primer, while an additional set of primers, starting with a F-primer on the
desired T2 mutation and ending at the C-terminus of ESAT-6 were generated to yield two
fragments (one from N-terminal CFP-10 to mutation(NM), another from mutation to C17

terminal ESAT-6 (MC)) (Table 3.1). Both of these fragments were then used as template
and amplified using the primer from N-terminal CFP-10 and C-terminal ESAT-6 to yield a
completed fragment with the mutation in between. After amplification, the fragments were
run in a 1% agarose gel, excised, and then purified via a QIAGEN gel extraction method.
The NM and MC fragments were then used as templates, and primers from N-terminal
CFP-10 and C-terminal ESAT-6 were used to amplify the completed PCR product. The
completed insert was then double digested using BAMHI and NCOI. Digested inserts and
vectors were ligated using T4 DNA ligase and transformed into DH5α competent cells

Table 1: Primers Used for Cloning. All the primers used for cloning are listed here. PMyNT
used overlap PCR, meaning two fragments were created separately, then combined by using
both fragments as a template and Forward Primer from fragment 1 and Reverse Primer from
fragment 2.
Vector and Mutation
pET22b-T2A
pET22b-T2Q
pET22b-T2R
pET22b-T2S

F-Primer Sequence
5'-AAGGATCCATGGCAGAGCAGCAGTGGAATTC-3'
5'-AAGGATCCATGCAAGAGCAGCAGTGGAATTC-3'
5'-AAGGATCCATGAGAGAGCAGCAGTGGAATTC-3'
5'-AAGGATCCATGAGTGAGCAGCAGTGGAATTC-3'

R-Primer Sequence
5'-TGGTGGTGGTGGTGGTGTGCGAACATCCCAGTG-3'
5'-TGGTGGTGGTGGTGGTGTGCGAACATCCCAGTG-3'
5'-TGGTGGTGGTGGTGGTGTGCGAACATCCCAGTG-3'
5'-TGGTGGTGGTGGTGGTGTGCGAACATCCCAGTG-3'

pMyNT -T2A

Fragment 1: 5'-GCCATGGCAGAGATATGGCAGAGATGAAGA-3'
Fragment 2: 5'-GAAACGGAGCAAAAACATGGCAGAGCAGCAGTGGAATTTC-3'

Fragment 1: 5'-GAAATTCCACTGCTGCTCTGCCATGTTTTTGCTCCGTTTC-3'
Fragment 2: 5'-TAGCGATATCGAATTCGGATCCTTATGCGAA-3'

pMyNT -T2Q

Fragment 1: 5'-GCCATGGCAGAGATATGGCAGAGATGAAGA-3'
Fragment 2: 5'-GAAACGGAGCAAAAACATGCAAGAGCAGCAGTGGAATTTC-3'

Fragment 1: 5'-GAAATTCCACTGCTGCTCTTGCATGTTTTTGCTCCGTTTC-3'
Fragment 2: 5'-TAGCGATATCGAATTCGGATCCTTATGCGAA-3'

pMyNT -T2R

Fragment 1: 5'-GCCATGGCAGAGATATGGCAGAGATGAAGA-3'
Fragment 2: 5'-GAAACGGAGCAAAAACATGAGAGAGCAGCAGTGGAATTTC-3'

Fragment 1: 5'-GAAATTCCACTGCTGCTCTCTCATGTTTTTGCTCCGTTTC-3'
Fragment 2: 5'-TAGCGATATCGAATTCGGATCCTTATGCGAA-3'

pMyNT -T2S
Pmh406 -T2A
Pmh406 -T2Q
Pmh406 -T2R
Pmh406 -T2S

Fragment 1: 5'-GCCATGGCAGAGATATGGCAGAGATGAAGA-3'
Fragment 2: 5'-GAAACGGAGCAAAAACATGAGTGAGCAGCAGTGGAATTTC-3'
5'-GAAACGGAGCAAAAACATGGCAGAGCAGCAGTGGAATTTC-3'
5'-GAAACGGAGCAAAAACATGCAAGAGCAGCAGTGGAATTTC-3'
5'-GAAACGGAGCAAAAACATGAGAGAGCAGCAGTGGAATTTC-3'
5'-GAAACGGAGCAAAAACATGAGTGAGCAGCAGTGGAATTTC-3'

Fragment 1: 5'-GAAATTCCACTGCTGCTCACTCATGTTTTTGCTCCGTTTC-3'
Fragment 2: 5'-TAGCGATATCGAATTCGGATCCTTATGCGAA-3'
5'-GAAATTCCACTGCTGCTCTGCCATGTTTTTGCTCCGTTTC-3'
5'-GAAATTCCACTGCTGCTCTTGCATGTTTTTGCTCCGTTTC-3'
5'-GAAATTCCACTGCTGCTCTCTCATGTTTTTGCTCCGTTTC-3'
5'-GAAATTCCACTGCTGCTCACTCATGTTTTTGCTCCGTTTC-3'

3.2 Expression and Purification of Proteins
The pET22b plasmids containing target genes were transformed into BL21 (DE3)C41 competent cells. A single colony was picked and grown overnight in 30ml of LuriaBertani broth (LB) as a start-up culture at 37°C while shaking at 250 RPM. Next, 5ml of
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the start-up culture was used to inoculate 1L of LB. The culture was then allowed to reach
an OD600 of 0.6-0.8, at which point the culture was induced by adding Isopropyl β-D-1thiogalactopyranoside (IPTG) to a final 1mM concentration; the culture was incubated for
a further 3-8 hours post induction. Proteins were purified by an on-column refolding
protocol, as previously mentioned (de Leon, 2007), using a Ni+ affinity column. The
protein resulting from the Ni+ elution is concentrated using a 3000 MWCO viva spin and
injected into a Superdex-75 size exclusion column for size exclusion chromatography.
Genes in pMyNT plasmid were electroporated into M. smegmatis. A single colony
was picked and allowed to culture for ~2 days at 37°C while shaking at 250 RPM in 7h9
medium supplemented with OADC as a start-up culture. Approximately, 10 ml of start-up
culture was used to inoculate 1L of 7H9 media supplemented with glucose (0.2%(w/v)),
glycerol (0.2%(v/v)), and tween-80(0.05%(v/v)). The 1L culture was incubated overnight or
until it reached an OD600 of 2.0. The culture was induced using 2g acetamide and allowed
to culture for 1 day. The protein is typically soluble and is purified by sonicating with
protease inhibitor cocktails. The sonicated sample was centrifuged at 15000RPM for 40
minutes. The supernatant was loaded onto a Ni+ affinity column. The purified protein was
concentrated using a 5000 MWCO viva spin to final 1ml volume. The concentrated
sample was injected into a Superdex-75 column for a size exclusion chromatography.
3.3 Generation of M. marinum strains
M. marinum KO strain was electroporated using the pMH406 plasmids. The
plasmid was electroporated at a voltage of 2500 U, capacitance of 25 µF, resistance of
1000 Ω. The sample was incubated in 10ml of 7h9 medium for 4 hours at 30°C. The
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sample was centrifuged and re-suspended into 1ml for plating. The plates were incubated
for 2 weeks at 30°C in darkness.
3.4 Growth Conditions for RAW 264.7 Cells
Raw 264.7 cells were used for infection. They were cultured in DMEM medium
containing 10% fetal bovine serum (FBS) with penicillin and streptomycin. The cells were
grown at 37°C with 5% CO2.
3.5 Separation of Heterodimer with ASB-14 or 6M Guanidine.
The CFP-10 and ESAT-6 heterodimer complex can be separated via incubation
with ASB-14 at 1X critical micelle concentration (8mM ASB-14) or 6M guanidine for 1 hour
or overnight, respectively, in 4°C. Following incubation, the proteins were purified using
a Ni+ affinity column. CFP-10 contains a hexa-histidine tag, while ESAT-6 does not
meaning that flow-through collected contains ESAT-6, while the elution sample consists
of CFP-10. If the sample is separated using ASB-14, it is diluted to lower the critical
micelle concentration of ASB-14 making the detergent weaker and easier to remove via
a thermos scientific detergent removal kit. Following the detergent removal kit, an acetone
precipitation was used to remove residual detergent. Leftover acetone was evaporated
and the sample was re-suspended in 1ml of a 25mM NaH2PO4 and 100mM NaCl buffer.
If the sample is separated under denaturing conditions with 6M guanidine, ESAT-6 and
CFP-10 will be concentrated using a 3000 MWCO or 5000 MWCO viva spin, respectively
into a 1ml sample. The concentrated 1ml sample from either source can be injected into
a Superdex-75 column for further purification and buffer exchange.
3.6 Liposome Leakage Assay
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Liposomes were prepared as previously described (Jacquez, 2012). Briefly, 1,2dioleoyl-sn-glycero-3-phosphocholine

and

1,2-dioleoyl-sn-glycero-3-[(N-(5-amino-1-

carboxypentyl)iminodiacetic acid)succinyl] (nickel salt) were mixed at appropriate ratios,
dried using nitrogen gas, and then placed under a vacuum overnight. The samples were
rehydrated and added 8-aminonapthalene-1,3,6 trisulfonic acid (ANTS)/p-xylene-bispyridinium bromide (DPX). Suspended liposomes were submitted through 6 freeze/thaw
cycles using ethanol with dry ice and hot water, respectively. The lipids were extruded
through a 0.2 µm membrane 20 times to form the liposomes. As the liposomes are
formed, high concentrations of ANTS and DPX will be entrapped inside liposomes, where
the ANTS fluorescence will be quenched by DPX. The liposomes were desalted using a
hitrap desalting column. Upon pore formation, ANTS and/or DPX will be released out of
the liposomes, resulting in de-quenching of ANTS fluorescence. The exhibited
measurable fluorescence was quantified in an ISS K2 phase modulation fluorometer.
3.7 Measuring Macrophage Cell Death Using the Cytotoxicity Assay.
Raw 264.7 macrophages were plated in 24 well plate at a concentration of 5X10 5
for infection the following day. After growing a viable culture of M. marinum, the bacteria
was prepared via a single cell preparation protocol, as previously described (Takaki, K.,
2013), to break up the cells which have a high tendency to form cellular clumps. Briefly,
the cells were washed with PBS and broken up using a high gauge needle. The cells
were centrifuged lightly and optical density OD600 was measured to determine bacterial
concentration. The M. marinum after single cell preparation was used to infect the Raw
264.7 macrophages at a multiplicity of infection (MOI) of 10 for 1 hour. Following the
infection the macrophages were washed 3 times to remove bacteria and incubated for 3
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hours. The macrophages were stained using calcein-AM and ethidium homodimer for 30
minutes, enabling visualization under a fluorescent microscope for green (live) and red
(dead) cells. The number of dead cells were quantified and compared throughout all the
strains.
3.8 Fluorescence Resonance Energy Transfer
Raw 264.7 macrophages were plated in 6 well plates at a concentration of 2.5X106
cells. M. marinum cultures were prepared using the previously described single cell
preparation technique in section 4.7. Cells were infected at an MOI of 10 for 2 hours.
Following infection, macrophages were washed 3 times using PBS. DMEM media with
10% FBS was added to the cells and incubated for ~2 days. The samples were then
excited at 409nm and emissions measured at 450nm and 535nm. The study works by
observing a change from 535nm (green) to 450nm (blue) as a result of a reaction between
the chemical probe and β-lactamase, as the bacteria escapes the phagosome it is
enclosed in, the β-lactamase expressed on the cell wall of the bacteria reacts with the
chemical probe causing a shift from green to blue fluorescence. The fluorescence was
compared as a ratio, with a higher blue/green ratio indicating a greater shift of bacteria
from phagosome into cytosolic space.
3.9 Western Blotting
The secretion and expression of ESAT-6 was measured using Western blotting.
M. marinum cultures were grown in 7h9 to mid-log phase. They were then washed with
PBS and passaged to Sauton’s media while normalizing all cultures to OD 600 of 0.8. They
were allowed to grow for two days until harvest. The cultures were centrifuged and the
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supernatant was used to detect secretion of ESAT-6, while the pellet was used to detect
expression of ESAT-6 within the cells. Supernatant of ESAT-6 culture was prepared by
concentrating using a 5000mwco viva spin at least 75x. The resulting culture was then
concentrated using a trichloroacetic acid precipitation. Cell lysate was resuspended in
1ml of PBS + protease inhibitor cocktail and sonicated at 30% amplitude pulsing for 30
seconds and resting for 1 minute 5 times.
3.10 NBD-Cl
NBD-Cl was used to determine the acetylation state of the different types of ESAT6 protein. A 1ml sample containing 6µM of proteins with 0.5mM NBD-Cl wias incubated
for 1 hour at room temperature. The samples were excited at 460nm and the emissions
at 535nm were recorded. The samples were measured within a period of 24 hours with
different intervals in between.
3.11 Mass Spectrometry
Acetylation will be confirmed via mass spectrometry. Here, the ESAT-6 protein
from M. smegmatis were tested to see if the acetylation or an increase of 42 Da is seen
as compared to WT ESAT-6 purified from E. coli, furthermore, T2S and T2A mutants
purified from M. smegmatis were also tested. The four purified proteins were analyzed by
2hr-1d-LC-MS/MS on QEClassic. For more reliable data, the four purified proteins were
digested via FASP-trypsin and pepsin. All peptide mixtures were analyzed by 2hr-1d-LCMS/MS on QEClassic. Following a PD2.1 search against a combined database containing
E. coli BL21 and M. smegmatis M1552 and other common contaminants was performed.
3.12 Native Gel
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The binding efficiency to CFP-10 from ESAT-6 purifed from E. coli was compared
to ESAT-6 purified from M. smegmatis via native gel electrophoresis. ESAT-6 from both
sources was incubated with CFP-10 at different molar ratios (0.5x, 1.0X, 1.5X, and 2.0X),
for 2 hours at room temperature. The samples were loaded onto a native gel to observe
for efficiency at which the proteins from a complex and for ability of ESAT-6 to deplete
CFP-10.
3.13 Surface Plasmon Resonance
The binding affinity of ESAT-6 was tested by using surface plasmon resonance.
CFP-10 was bound to a CM5-sensor chip via amine coupling. N-hydroxysuccinimide, and
N-ethyl-N’-(3-dimethylaminopropyl carbodiimide hydrochloride will be injected. CFP-10 at
200nM was injected at 5µl/minute followed by ethanolamine-HCl. ESAT-6 purified from
E. coli was passed through the sensor-chip at equimolar concentration as CFP-10.
Following this experiment ESAT-6 purified from M. smegmatis was passed through the
sensor-chip, to which CFP-10 was attached. The binding affinity of the two proteins was
compared.
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Chapter 4: Results
4.1 Mutated ESAT-6 Was Generated and Proteins Were Purified
Following PCR, the mutations T2/A, T2/Q, T2/R, T2/S at ESAT-6 were achieved
as shown on figure 3. Mutated ESAT-6 was generated in pET22b for expression of ESAT6 in E. coli, pMyNT for expression of CFP-10 and ESAT-6 as a heterodimer in M.
smegmatis, and pMH406 for complementation with the ESAT-6 gene into a KO M.
marinum strain.

Figure 3: Mutations generated in ESAT-6: Threonine 2 was mutated to either A, Q, R or
S. Mutations were created for lone ESAT-6, Complexed ESAT-6 or in ESAT-6 for
complementation into M. marinum.

Following generation of plasmids, proteins were
purified using an on-column refolding protocol for
unsoluble ESAT-6 and standard Ni+ affinity for the
soluble heterodimer. Proteins from either source were
Figure 4: Different Fractions
for purified ESAT-6
complexed with CFP-10 or
lone ESAT-6: Typical fractions
for any protein heterodimer (2)
or lone ESAT-6 (3).

further purified using size exclusion chromatography.
All purified proteins were highly pure as evidenced by
SDS-PAGE (Figure 4). Heterodimer protein generally
consisted in nearly a 1:1 expression of CFP-10 to

ESAT-6.
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4.2 ANTS/DPX Assay Reveals T2Q, T2R and T2A Mutants Failed to Lyse
Liposomes

Figure 5: Liposome Leakage Assay of complexed ESAT-6: WT ESAT-6 purified from
E. coli was used as a positive control for membrane lysing activity. WT heterodimer ESAT6 showed less activity that WT ESAT-6. None of the mutations successfully induced
liposome membrane lysis.

Results indicate the ESAT-6 mutants complexed with CFP-10, were unable to induce
the same membrane lysing ability as ESAT-6 alone. The activity of complexed ESAT-6
and CFP-10 was approximately half of the intensity that lone ESAT-6 had (Figure 5). A
possible explanation could be that the ESAT-6 and CFP-10 complex was not dissociated
completely, thus not having the same activity wild-type ESAT-6. The mutants containing
T2Q, T2R or T2A mutations of ESAT-6 failed to induce fluorescence, indicating that the
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proteins were incapable of lysing the membrane of the liposomes. To confirm that ESAT6 activity was not hindered by the mutations, ESAT-6 proteins containing each of the
mutations were purified from E. coli and compared to WT ESAT-6 (Figure 6). These
ESAT-6 mutated proteins showed similar membrane-lysing activity as WT ESAT-6
highlighting that the mutations themselves did not affect the activity of ESAT-6. Both
figures indicate the importance of ESAT-6 and CFP-10 interaction. When complexed
activity of ESAT-6 is not possible, all mutants were incapable of lysing liposomal
membranes. However, ESAT-6 purified alone confirmed the activity of ESAT-6 was
unaffected by the mutations. Data suggests the separation of ESAT-6 from CFP-10 was
hindered as a result of the mutations, explaining why complexed ESAT-6 with mutations
failed to induce membrane lysis.

Figure 6 ESAT-6 activity remains despite mutations: ESAT-6 purified by itself
showed similar activity regardless of mutations.
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4.3 Secretion of ESAT-6 was Revealed Using Western Blot
Secretion of ESAT-6 after complementation of M. marinum with either WT or mutated
species was confirmed via immunoblotting. ESAT-6 was detected in both culture filtrate
(CF) and cell lysate (CL) for all strains with the exception of KO as expected (Figure 7).
Blotting against the AG85 complex was used as a loading control for this experiment
given that the complex is a secreted protein, which was detected in both CL and CF of
all generated strains. As a control for secretion GroEL, a protein found only as an
integral cell membrane protein, was blotted against. As expected none was found in CF
but was clearly observed in CL samples. This assay served as a control for in vivo
experiments. Detection of ESAT-6 in both CL and CF confirmed the protein’s
expression and release was not hindered by the mutations.

Figure 7: ESAT-6 is being secreted: ESAT-6 secretion and expression is unaffected by
mutations (3,4). AG85 was used as a positive control for protein secretion and expression
(1,2), while GroEL was used to control for secretion (5,6).
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4.4 Mutated ESAT-6 Had Less Impact on Raw 264.7 Macrophages
Cytotoxicity studies revealed, in vivo, the detrimental effects of a mutated ESAT6. M. marinum complemented with ESAT-6 containing T2Q, T2R, or T2A mutations
caused minimal cell death compared to the Wild-Type M marinum or strains complement
with WT-ESAT-6 or T2S mutation in ESAT-6 (Figure 8). The macrophages infected with
the KO strain as well as PBS, which served as a negative and vehicle control,
respectively, caused negligible cell death indicating there were no additional factors
affecting cell death. The strain complemented with WT ESAT-6 showed similar activity to
the WT M. marinum strain demonstrating that electroporation of the WT ESAT-6 gene
could restore activity akin to WT rather than intermediately as the T2Q, T2R, and T2A
mutants. The T2S mutant showed similar activity as did the WT, indicating that a residue
with similar biochemical properties retains similar function.

Figure 8: Differential Cytotoxicity of M. marinum strains: Mutated ESAT-6 showed
defected infection. WT, complemented strain (MmΔE6/C10(WT)) and T2/S
(MmΔE6/C10(T2S)) mutant retained significantly higher activity than did
T/2Q(MmΔE6/C10(T2Q)), T2/R (MmΔE6/C10(T2R)) and T2/A (MmΔE6/C10(T2A))
mutants.
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4.5 Fluorescence Resonance Energy Transfer Revealed Mutated ESAT-6 Had
Significantly Lower Cytosolic Translocation

Figure 9: Fluorescence Resonance Energy Transfer: The different mutations had
negligible blue/green ratio indicating small amounts of cytosolic translocation. However, the
noticed translocation may be greatly reduced, a negative control containing only PBS
showed similar ratios. Undoubtedly, S mutant complemented KO strain with WT ESAT-6,
and WT M. marinum strain all showed a higher blue/green ratio.

As shown by fluorescence resonance energy transfer, the T2Q, T2R, T2A mutants
had a significantly lower intensity than did T2S, WT M. marinum and WT ESAT-6
complemented KO strains. Once more, the KO and negative control had negligible shift
in blue/green ratio (Figure 8). Interestingly, the blue/green ratio from T2Q, T2R and T2A
was nearly the same as KO and negative control. This data suggests a small portion of
the blue/green shift observed in the T2/Q, T2/R, or T2/A mutants may be due to other
factors, rather than the activity of the strains themselves. The T2/S strain, WT M. marinum
and KO complemented with WT ESAT-6 showed significantly higher blue/green ratio.
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Since the acetylation negative strains are presumed to have no or severely defected
membrane lytic activity, the results here are consistent with what was previously
observed, the mutants are unable to translocate into the cytosol as opposed to the active
strains.
4.6 Successful Separation of Heterodimer was Achieved using ASB-14 or 6M
Guanidine

Figure 10 ASB-14 successfully separates ESAT-6/CFP-10 heterodimer: Use of
multiple detergents revealed zwitterionic detergents to be the most effective at disrupting
ESAT-6/CFP-10 interaction as observed by ASB-14 and LDAO. All samples were tested
at 1X critical micelle concentration.

Treatment with detergents revealed that high concentration of detergents used
will disrupt interaction between ESAT-6 and CFP-10 allowing for separation of the
heterodimer complex. Incubation with ASB-14, LDAO, B-OG, or DDM at 10X critical
micelle concentration will separate the heterodimer (data not shown). Incubation with
detergents at 1X CMC revealed a stronger disruption of the heterodimer with ASB-14.
LDAO, another zwitterionic detergent appears to also cause separation of the
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heterodimer at 1X CMC, but still to a lesser extent than ASB-14. Following incubation with
detergents, the samples were run through a Ni+ affinity chromatography to separate
ESAT-6 which lacks a his-tag from CFP-10. Flow-through sample consisted of ESAT-6
that was washed out as unbound sample, while elution sample consisted of CFP-10
(Figure 10). Following separation of the proteins, extensive detergent removal was
performed.

Figure 11: 6M guanidine treatment separates ESAT-6/CFP-10 heterodimer:
ESAT-6 and CFP-10 interaction was disrupted by 6M guanidine, flowthrough
samples consisted of ESAT-6, devoid of any CFP-10.

Treatment using 6M guanidine successfully separated the heterodimer
complex. Following an overnight incubation with 6M guanidine samples were purified
using a Ni+ affinity chromatography. Once more unbound samples represented ESAT-6
while elution samples consisted of CFP-10. Samples were dialyzed using tris-buffered
saline to remove excess urea or were submitted to buffer exchange chromatography
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using a superdex 75 column. Separation and recovery of proteins was observed via SDSPAGE (Figure 11).
4.7 NBD-Cl Revealed Lack of Acetylation for Mutated ESAT-6; Confirmed
Acetylated ESAT-6 from M. smegmatis

Figure 12: Mutated ESAT-6 contains Free N-terminal site: Evidence of differential Nterminal acetylation was observed. As suspected, protein free of N-terminal acetylation
showed higher fluorescence indicating a free N-terminal site. ESAT-6 purified from M.
smegmatis showed a much lower signal implying a blocked N-terminal site presumably by
an acetyl group.

The heterodimer complex was incubated with ASB-14 to disassociate the complex.
The resulting ESAT-6 proteins were tested using using 4-chloro-7-nitrobenzofurazan
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(NBD-Cl), a fluorophore that binds at the N-α-terminal site of a protein, and emits
fluorescence after binding. Proteins with an acetyl group have a blocked binding site for
NBD-Cl, which will not allow the fluorophore to bind and emit fluorescence. This study
revealed more intense fluorescence on ESAT-6 purified from E. coli and the mutants
purified from M. smegmatis than WT ESAT-6 from M. smegmatis. The T2Q, T2R, and
T2A mutants had similar intensity to ESAT-6 from E. coli, indicating the lack of acetylation.
The ESAT-6 protein from M. smegmatis had less intensity than the other types of ESAT6 indicating it to be acetylated (Figure 12). Furthermore, incubation period of 24 hours
significantly increased intensity on other proteins while rise in intensity for presumably
acetylated ESAT-6 was nonexistent.
4.8 Mass Spectrometry Distinguishes N-α-terminally Acetylated VS. Un-Acetylated
Proteins
Intact protein analysis revealed a methionine loss with acetylation for WT ESAT6 from M. smegmatis representing over 95% of abundant species. T2S mutant revealed
similar results with the acetylated protein representing about 80% of abundant
species. WT ESAT-6 from E. coli showed acetylation without a methione loss
representing ~40% of abundant species, lastly T2A showed intact species with a
methionine loss representing 99% of abundant species (data not shown). For more
conclusive results trypsin and pepsin digestions of proteins were performed. Resultant
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peptides were analyzed via mass spec and a PD2.1 search was performed looking for all
acetylation and oxidations of the proteins. Pepsin digestions showed results consistent
Protein Name

Sequence Coverage

N-terminal Modification

Total Modifications

Ms ESAT-6

99%

Met-loss; Acetyl-Thr

1 Acetyl; 2 Oxidation

EC ESAT-6

87%

N-terminus not recovered

2 Oxidation

Ms ESAT-6 (T2A)

63%

N-terminus not recovered

1 Oxidation

Ms ESAT-6 (T2S)

99%

Met-loss; Acetyl-Ser

1 Acetyl; 1 Oxidation

Table 2: Summary of mass spectrometry results following pepsin digestion: ESAT-6
from M. smegmatis and T2S mutated ESAT-6 show acetylation consistent with other
findings. Other proteins did not have successful recovery of N-terminal sequence and
cannot be assumed to lack acetylation.

with previous mass spec analyses; however, some samples did not have N-terminus
recovery (Table 2). To supplement previous findings, trypsin digestion was performed and
N-α-terminal acetylation for WT ESAT-6 and T2S from M. smegmatis was confirmed. WT
ESAT-6 purified from E. coli did in fact reveal acetylation, but none was found at the NProtein Name

Sequence Coverage

N-terminal Modification

Total Modifications

Ms ESAT-6

99%

Met-loss; Acetyl-Thr

4 Acetyl; 2 Oxidation

EC ESAT-6

100%

Oxidized-Meth

9 Acetyl; 3 Oxidation

Ms ESAT-6 (T2A)

99%

Met-loss

5 Acetyl; 2 Oxidation

Ms ESAT-6 (T2S)

99%

Met-loss; Acetyl-Ser

4 Acetyl; 2 Oxidation

Table 3: Summary of mass spectrometry results following trypsin digestion: Results
here revealed an array of modifications to the resulting peptides. Over 90% of sequence
recovery was obtained after analysis. ECE6 refers to ESAT-6 purified from E. coli, while
MSE6 refers to ESAT-6 purified from M. smegmatis.

terminus. Consistent with previous findings, methionine loss did not occur for ESAT-6
from E. coli. Lastly, as was expected T2A showed no signs of N-α-terminal acetylation
(Table 3; Figure 13). Furthermore, oxidation of methionine is a common modification and
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was helpful to indicate a conserved methionine in E. coli ESAT-6. The search after trypsin
digestion also revealed other acetylations in different residues.

Figure 13: Sequence recovery of different ESAT-6 peptides from trypsin digestion:
Here all modifications to the different types of ESAT-6 protein are denoted in their
respective location. Acetylation is indicated by an “A” above the acetylated residue, while
oxidations are denoted by an “O” above the affected residue. Green highlighting represents
the sequence recovery.

4.9 Native Gel Reveals ESAT-6 From E. coli binds less efficiently than ESAT-6
from M. smegmatis

A

B

Figure 14: ESAT-6 from M. smegmatis is less prone to form a heterodimer:
(A)Esat-6 purified from E. coli depleted CFP-10 at 1.5X molar ratio. (B) ESAT-6
purifed from M. smegmatis depleted ESAT-6 at 2.0X molar ratio.
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Following incubation, ESAT-6 from E. coli depleted CFP-10 to form the
heterodimer complex which migrated lower than CFP-10 but slightly above ESAT-6
(Figure 14A). ESAT-6 purified from M. smegmatis formed a complex with CFP-10 but
failed to deplete CFP-10 at lower molar ratios (Figure 14B). The native gel in this study
supports the theory that acetylation might hinder the binding affinity between CFP-10 and
ESAT-6. A non-acetylated ESAT-6 from E. coli is able to associate more efficiently than
an acetylated ESAT-6 from M. smegmatis.
4.10 Surface Plasmon Resonance Reveals Differential Binding Affinity of
Acetylated Vs Un-acetylated ESAT-6

Figure 15 ESAT-6 from M smegmatis displays lower binding affinity than ESAT-6
from E. coli: Evidenced from surface plasmon resonance, ESAT-6 from M. smegmatis
had a higher KD than ESAT-6 from E. coli
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CFP-10 was bound to a CM5 sensor chip using amine coupling. As evidenced
from previous data, ESAT-6 from M. smegmatis contains acetylation at its N-terminus,
while ESAT-6 from E. coli does not. Preliminary studies revealed the difference in
binding affinity, as the un-acetylated ESAT-6 represented near double the binding
affinity of an acetylated species.
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Chapter 5 Discussion, Conclusion, Future Direction
5.1 Discussion
The experiments here reveal the importance of N-α-terminal acetylation in the
pathogenesis of ESAT-6. Removal of the acetylation mechanism results in significantly
reduced activity. The physiological importance of N-α-terminal acetylation can’t be
overstated for this reason. Results indicate that the ESAT-6 mutants, when complexed
with CFP-10, were unable to induce the same membrane lysing ability as the wild type.
When they were alone (without CFP-10), the ESAT-6 mutants showed significantly
defected membrane-lysing activity, suggesting that the mutants inhibited the pHdependent dissociation of ESAT-6 from CFP-10 without affecting the activity of ESAT-6
itself. Cytotoxicity studies revealed in vivo the detrimental effects of a mutated ESAT-6.
The T2/Q, T2/R, and T2/A mutants caused diminutive cell death, compared to Wild-Type
M. marinum, T2/S mutant, and KO strain complemented with WT ESAT-6. The additional
T2/S mutant, showed similar activity than did the wild-type, indicating a residue with
similar biochemical properties, did in fact retain similar function. FRET revealed the
mutations T2/Q, T2/R, and T2/A resulted in less cytosolic translocation than Wild-Type
M. marinum, T2/S mutant, and KO strain complemented with WT ESAT-6, reiterating the
significance of N-α-terminal acetylation to M. marinum. The results clearly highlight the
importance of threonine-2 and more importantly, the effect N-α-terminal acetylation has
on the activity of ESAT-6. Just as importantly, western blotting confirmed the secretion of
ESAT-6 indicating no other factors had been affected by the mutations. The attenuated
virulence and lower cytosolic translocation highlights the physiological importance of Nα-terminal acetylation and differential liposome lysing ability between complexed and lone
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ESAT-6, hints the mutations on the ESAT-6 protein render it incapable of efficient
dissociation from its molecular chaperone.
Perhaps one of the more important aspects of this project was the separation of
the heterodimer complex. Through this separation, further characterization of ESAT-6
was enabled, as a reliable method to isolate acetylated ESAT-6 was created. NBD-Cl
testing demonstrated more fluorescence on ESAT-6 purified from E. coli and the mutants
purified from M. smegmatis than the Wild-Type ESAT-6 from M. smegmatis. NBD-Cl will
only show fluorescence when it binds to proteins at the site where N-α-terminal
acetylation would take place. E. coli does not contain the exact same N-α-terminal
acetyltransferases present in M. smegmatis, therefore ESAT-6 purified from E. coli should
show more activity than ESAT-6 purified from M. smegmatis. The mutants purified from
M. smegmatis showed similar activity to E. coli, as a clear indication that N-α-terminal
acetylation was not present. Furthermore, mass spectrometry data conclusively reveals
the state of acetylation of all proteins tested. Interestingly, acetylation was found on E.
coli ESAT-6. Mass indicated no methionine loss, and therefore it was hypothesized the
acetylation observed was resultant from another mechanism of acetylation. Trypsin
digestion and subsequent search clearly proved this hypothesis true. Interestingly, other
residues demonstrated clear signs of acetylation. The characterization or identification of
other acetylated residues has not been implicated before and could serve as a future
study. Native gel shift assay revealed a very important property from the acetylated
ESAT-6. The protein does not have the same ability to deplete CFP-10 as its unacetylated counterpart does. This clearly indicates the effect acetylation has on the
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binding affinity of ESAT-6 and CFP-10. Furthermore, preliminary studies with surface
plasmon resonance reveals a two-fold difference between the different types of ESAT-6
Presently, there is debate among the scientific community whether ESAT-6 enacts
pH dependent membrane lysing ability or weather ESAT-6 dissociates under acidic
conditions. A discrepancy between acetylated ESAT-6 and non-acetylated ESAT-6 was
revealed between conflicting studies. This study demonstrates the importance of N-αterminal acetylation in the pathogenesis of Mtb, and suggests acetylation may play a role
in the dissociation of the heterodimer complex formed by CFP-10 and ESAT-6. In the
present study, surface plasmon resonance revealed a difference between the binding
affinities of modified or non-modified species of ESAT-6. Future studies testing for binding
affinity will include a comparison between the effects acidic and neutral pH on either
protein. It is expected to see a greater shift in binding affinity, with acetylated ESAT-6
binding weaker under acidic conditions as compared to a non-acetylated ESAT-6 at near
neutral pH.
5.2 Conclusion
The proposition that N-α-terminal acetylation has an effect on the CFP-10 and
ESAT-6 heterodimer dissociation is supported. Mutations on ESAT-6 as a complex with
CFP-10 revealed no membrane lysing ability. However the very same mutations
performed on lone ESAT-6 retained their activity. The intense reduction of infectivity and
decreased cytosolic translocation of M. marinum by a single molecular process, serves
as an exemplar model for possible therapeutic options to treat Mtb. Furthermore, it is
observed that acetylation of the mutants is absent as indicated by NBD-Cl testing and
mass spectrometry. Native gel and surface plasmon resonance revealed differential
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binding between acetylated and un-acetylated ESAT-6. Therefore, N-α-terminal
acetylation plays an important role in the dissociation between the CFP-10 and ESAT-6
heterodimer complex.
5.3 Future Direction
T2 of ESAT-6 appears to play an essential role in dissociation of ESAT-6 from
CFP-10. The role of T2 acetylation in Mtb pathogenesis has not been well studied.
Several vaccines currently in development or in testing stages are ESAT-6 based. This
study provides evidence that the lack of acetylation could have a detrimental effect on the
pathogenesis of TB; changing direction in the treatment development for Mtb. Current
therapeutics generally target mycobacteria specific mechanisms, such as the disruption
of mycolic acids by ethambutol. New treatment options in the future could include
inhibitors for the acetylation of T2 at ESAT-6. More characterization is still needed
underlying the process of N-α-terminal acetylation and what role this modification plays
in dissociation of ESAT-6. As previously mentioned, studies testing for the different
binding affinity including different pH and acetylation state would help identify
discrepancies of the scientific community. The natural evolution of this study is to
identifying the N- α -terminal acetyltransferase responsible for this mechanism. After
identifying the enzyme, it could serve a special purpose. For example, a study to
characterize it would provide with insightful information and may identify key binding sites
for therapeutic targets.

Similarly, plenty other post translational modifications were

revealed as a result of mass spectrometry. Another possible direction could include
identifying the extent of those other modifications and what their purpose is. More
importantly, this study opens new doors for possible therapeutic options. The N-α42

terminal acetyltransferase for mycobacteria appears to differ from others. Since this is a
particular property of this genus, then it even more possible to suggest what therapeutic
options could arise. Given that a change to this solitary amino acid can disrupt the
acetylation at the N-terminus, and lack of this modification causes a strong change in the
phenotype of the bacteria, many possible therapeutic options could arise.
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